Showing results (421-430 of 844) with videos related to

Sort By:
Pageof 85
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2005
Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancerF Nolè, C Catania, G Sanna, et al.
Ecancermedicalscience|January 26, 2012
Correlation between administered treatment and patient's living willB Andreoni, A Goldhirsch, R Orecchia, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1983
Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancerF Cavalli, A Pedrazzini, G Martz, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2009
Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancerFranco Nolè, D Crivellari, R Mattioli, et al.
Oncology Reports|May 19, 2011
Cisplatin, etoposide and bleomycin infusion (PEBi regimen) in good-risk patients with germ cell tumorsM Colleoni, R Graffeo, G Martinelli, et al.
Oncotarget|June 21, 2016
Impact of autoimmune diseases on outcome of patients with early breast cancerCarmen Criscitiello, Vincenzo Bagnardi, Angela Esposito, et al.
The Lancet. Oncology|May 21, 2018
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysisFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Primary endocrine therapy for advanced breast cancer: to start with tamoxifen or with medroxyprogesterone acetate?M Castiglione-Gertsch, S Pampallona, M Varini, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II studyT Cerny, G Martinelli, A Goldhirsch, et al.
Pageof 85